ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,634, issued on Aug. 12, was assigned to KOREA BASIC SCIENCE INSTITUTE (Daejeon, South Korea).

"Single domain antibody targeting AlphaVBeta3 integrin" was invented by Ki-Yuk Chang (Seoul, South Korea), Kwan-Soo Hong (Cheongju-si, South Korea), Chan-Woo Kim (Suwon-si, South Korea), Hyeon-Seung Lee (Daejeon, South Korea) and Hyun-Min Kim (Gimje-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are an AlphavBeta3 integrin targeting single-domain antibody and various applications thereof. The AlphavBeta3 integrin targeting single-domain antibody exhibits high binding ability to AlphavBeta3 integrin related to angiogenesis, excellen...